opens new tab, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said ...

, opens new tab unit Google said on Friday it would invest $3 billion to set up a data center campus in Indiana and expand sites in Virginia. A boom in artificial intelligence applications has ...

(Reuters) - Boeing (NYSE:BA) said on Friday that it has closed a deal with aero supplier GKN (LON:GKN) Aerospace and its parent company Melrose Industries (LON:MRON) for a plant in St. Louis. The deal ...

BOGOTA, April 26 (Reuters) - U.S. car maker General Motors (GM.N) , opens new tab will close its manufacturing operations in Colombia and Ecuador, the company said in a statement on Friday ...

The deal immediately transitions GKN's St. Louis site's operations in support of ... Editing by Shailesh Kuber Our Standards: The Thomson Reuters Trust Principles. Elon Musk's X has policies ...

(Reuters) - Boeing (NYSE ... The deal immediately transitions GKN's St. Louis site's operations in support of F/A-18 and F-15 jet programs to Boeing, and the manufacturing of critical components ...

, opens new tab breached the $2 trillion market value mark for the first time since November 2021 on Friday, as investors cheered the Google parent announcing its first-ever dividend and a $70 ...

Our Standards: The Thomson Reuters Trust Principles. Anisha De is an Editor on the Digital Production desk in Bangalore, India. She oversees a team of journalists responsible for curating the ...

NEW YORK, April 25 (Reuters) - The Gateway Pundit, a far-right news site, filed for bankruptcy Wednesday, following litigation by election workers and others who faced harassment after the site ...

, opens new tab have settled Acuitas' lawsuit demanding credit for inventions related to COVID-19 vaccines, according to a filing on Thursday in Virginia federal court. Acuitas sued CureVac last ...

, opens new tab in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

"You have to be here and you have to be part of that innovation cycle," Chief Executive Ola Kaellenius told Reuters on the sidelines of the show. "We have been steadily growing our partner group ...